- Home
- MRKR vs BFRG Comparison
MRKR vs BFRG Comparison
Compare MRKR & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- BFRG
- Stock Information
- Founded
- MRKR N/A
- BFRG 2017
- Country
- MRKR United States
- BFRG United States
- Employees
- MRKR N/A
- BFRG N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- BFRG Retail: Computer Software & Peripheral Equipment
- Sector
- MRKR Health Care
- BFRG Technology
- Exchange
- MRKR Nasdaq
- BFRG Nasdaq
- Market Cap
- MRKR 13.7M
- BFRG 16.4M
- IPO Year
- MRKR N/A
- BFRG 2023
- Fundamental
- Price
- MRKR $0.89
- BFRG $1.22
- Analyst Decision
- MRKR Strong Buy
- BFRG
- Analyst Count
- MRKR 3
- BFRG 0
- Target Price
- MRKR $13.17
- BFRG N/A
- AVG Volume (30 Days)
- MRKR 2.6M
- BFRG 97.0K
- Earning Date
- MRKR 08-14-2025
- BFRG 08-13-2025
- Dividend Yield
- MRKR N/A
- BFRG N/A
- EPS Growth
- MRKR N/A
- BFRG N/A
- EPS
- MRKR N/A
- BFRG N/A
- Revenue
- MRKR $5,388,071.00
- BFRG $33,257.00
- Revenue This Year
- MRKR N/A
- BFRG N/A
- Revenue Next Year
- MRKR $15.82
- BFRG N/A
- P/E Ratio
- MRKR N/A
- BFRG N/A
- Revenue Growth
- MRKR 44.55
- BFRG N/A
- 52 Week Low
- MRKR $0.81
- BFRG $1.17
- 52 Week High
- MRKR $5.95
- BFRG $4.84
- Technical
- Relative Strength Index (RSI)
- MRKR 30.85
- BFRG 39.83
- Support Level
- MRKR $0.81
- BFRG $1.18
- Resistance Level
- MRKR $0.98
- BFRG $1.27
- Average True Range (ATR)
- MRKR 0.10
- BFRG 0.07
- MACD
- MRKR -0.03
- BFRG 0.01
- Stochastic Oscillator
- MRKR 14.39
- BFRG 31.43
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.